These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 27092912

  • 1. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini M, Vescovi P.
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [Abstract] [Full Text] [Related]

  • 2. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
    Soares AL, Simon S, Gebrim LH, Nazário ACP, Lazaretti-Castro M.
    Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
    [Abstract] [Full Text] [Related]

  • 6. Osteopathology induced by bisphosphonates and dental implants: clinical observations.
    Jacobsen C, Metzler P, Rössle M, Obwegeser J, Zemann W, Grätz KW.
    Clin Oral Investig; 2013 Jan; 17(1):167-75. PubMed ID: 22415216
    [Abstract] [Full Text] [Related]

  • 7. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
    Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI.
    Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
    [Abstract] [Full Text] [Related]

  • 8. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
    Otto S, Schnoedt EM, Troeltzsch M, Kaeppler G, Aljohani S, Liebermann A, Fliefel R.
    J Oral Implantol; 2023 Feb 01; 49(1):39-45. PubMed ID: 35446931
    [Abstract] [Full Text] [Related]

  • 9. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
    Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM.
    Clin Implant Dent Relat Res; 2014 Oct 01; 16(5):751-61. PubMed ID: 23445465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S, Fliefel R, Ihbe J, Kühnisch J, Ehrenfeld M, Otto S.
    J Craniomaxillofac Surg; 2017 Sep 01; 45(9):1493-1502. PubMed ID: 28687467
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S, Hayashida S, Funahara M, Sakamoto Y, Kojima Y, Yanamoto S, Umeda M.
    PLoS One; 2018 Sep 01; 13(7):e0201343. PubMed ID: 30048523
    [Abstract] [Full Text] [Related]

  • 14. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
    Famili P, Quigley S, Mosher T.
    Compend Contin Educ Dent; 2011 Sep 01; 32(6):E106-9. PubMed ID: 23738968
    [Abstract] [Full Text] [Related]

  • 15. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A, Bettini G, Totola A, Saia G, Nocini PF.
    J Oral Maxillofac Surg; 2010 Jul 01; 68(7):1662-6. PubMed ID: 20561470
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients.
    Matsuo A, Hamada H, Takahashi H, Okamoto A, Kaise H, Chikazu D.
    Odontology; 2016 Sep 01; 104(3):363-71. PubMed ID: 25956267
    [Abstract] [Full Text] [Related]

  • 17. Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score-matched study.
    Ryu JI, Kim HY, Kwon YD.
    Clin Oral Implants Res; 2021 Apr 01; 32(4):437-447. PubMed ID: 33452837
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy.
    Mozzati M, Arata V, Giacomello M, Del Fabbro M, Gallesio G, Mortellaro C, Bergamasco L.
    J Craniofac Surg; 2015 May 01; 26(3):749-55. PubMed ID: 25974785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.